The social development bank in Europe

CYCLHAD

  • Approval date

    28 September 2018

  • Borrower

    SAS CYCLHAD

  • Country

    France

  • Loan size

    € 42 000 000

  • Line of action

    Sustainable and inclusive growth

  • Status

    In progress

An additional loan request for an amount of LD 1793 (2013) to a total amount of € 92 million, corresponding to 48% of the total cost, to part-finance the acquisition and exploitation of the System of Research and Treatment in Hadrontherapy (SRTH) prototype. Final beneficiairies will be people affected by cancer, who will have access to an innovative cancer treatment therapy.

Contributing to the fight against cancer in France

Project in focus

Read